BioSavita

BioSavita, a biopharmaceutical company, leverages high throughput synthetic DNA technologies and genetically engineered yeast strains to rapidly manufacture fully functional antibodies, single domain antibodies, antibody-drug conjugates, and fusion proteins. Founded with the mission to accelerate the development of novel biological drugs and vaccines, BioSavita collaborates with biopharmaceutical companies and government agencies to bring innovative treatments to market efficiently and cost-effectively.

Notable figures affiliated with BioSavita include experts in synthetic biology and biopharmaceutical development. The company has achieved significant milestones in biologics development, particularly in creating a versatile platform using Saccharomyces cerevisiae yeast strains. This technology has positioned BioSavita as a key player in the rapid production of biologics, contributing to advancements in healthcare by enabling quicker responses to emerging health threats and facilitating the development of new therapeutics.